Company type
Biotechnology company focused on the development and commercialization of gene therapies for the treatment of neurological disorders.Funding rounds
Series D
( )
| Investor | Profile | Country | |
|---|---|---|---|
| |
Investor Growth Capital Inc (IGC) | The wholly owned venture capital arm of Investor AB |
| Investor | Profile | Country | |
|---|---|---|---|
| |
Alta Partners LP | Venture capital firm based in San Francisco which invests primarily in biotechnology and life science companies. |
Investment activity status
Active investor